Published in
Dove Press, ClinicoEconomics and Outcomes Research, p. 299
DOI: 10.2147/ceor.s34188
Links
- ORCID
- Dove Press | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [eprints.whiterose.ac.uk] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Societal savings in patients with advanced non-squamous non-small-cell lung cancer receiving bevacizumab-based versus non-bevacizumab-based treatments in France, Germany, Italy, and Spain
Journal article published in 2012 by
Johanna Lister,
Sanja Stanisic,
Klaus Kaier 
,
Christian Hagist,
Dmitry Gultyaev,
Stefan Walzer
,
Christian Hagist,
Dmitry Gultyaev,
Stefan Walzer
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Data provided by 